Form 4 for SUPN SUPERNUS PHARMACEUTICALS, INC.
Accepted 2022-12-30 00:00:00 ET · period of report 2022-12-28 · accession 0001104659-22-131398 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-12-30 | 2022-12-28 | SUPN | NEWHALL CHARLES W III | Dir | M - OptEx | $7.90 | +8,722 | 110.5K | +9% | +$68.9K |
| D | 2022-12-30 | 2022-12-28 | SUPN | NEWHALL CHARLES W III | Dir | M - OptEx | $0.00 | -8,722 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-28 | M | A | 8,722 | $7.90 | 110,453 | D | — | — | |
| 2 | Derivative | Director Stock Option (Right to Buy) | 2022-12-28 | M | D | 8,722 | $0.00 | 0 | D | $7.90 · 2014-02-05 to 2023-02-05 | 8,722 Common Stock |